Motonobu Nakamura
- Dermatology top 0.5%
- Dermatology and Skin Diseases 22
- Cutaneous lymphoproliferative disorders research 12
- Urology top 1%
- Immunology top 2%
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 25
- Immunology and Allergy top 5%
-
- Bladder and Urothelial Cancer Treatments 31
- Urinary and Genital Oncology Studies 20
-
- Prostate Cancer Treatment and Research 19
- Prostate Cancer Diagnosis and Treatment 12
-
- Drug-Induced Adverse Reactions 14
- Cited by
- DermatologyUrologyImmunology
- Journals
- International Journal of Molecular Sciences (11 papers)Anticancer Research (10 papers)The Journal of Dermatology (9 papers)
- Partner nations
- JapanGermanyUnited States
In The Last Decade
Motonobu Nakamura
169 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Dermatology 872
- Urology 442
- Immunology 1.0k
- Oncology 871
- Immunology and Allergy 176
Countries citing papers authored by Motonobu Nakamura
This map shows the geographic impact of Motonobu Nakamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Motonobu Nakamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Motonobu Nakamura more than expected).
Fields of papers citing papers by Motonobu Nakamura
This network shows the impact of papers produced by Motonobu Nakamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Motonobu Nakamura. The network helps show where Motonobu Nakamura may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Motonobu Nakamura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 6 | |
| 6 | 2022 | 1 | |
| 7 | 2022 | 1 | |
| 8 | 2021 | 1 | |
| 9 | 2021 | 0 | |
| 10 | 2021 | 17 | |
| 11 | 2021 | 9 | |
| 12 | 2020 | 2 | |
| 13 | 2018 | 5 | |
| 14 | 2017 | 6 | |
| 15 | 2017 | 3 | |
| 16 | 2017 | 6 | |
| 17 | 2012 | 25 | |
| 18 | 2011 | 9 | |
| 19 | 2010 | 37 | |
| 20 | Macrophage colony stimulating factor inhibits experimental liver metastases from colon cancer. | 1995 | 1 |
About Motonobu Nakamura
Motonobu Nakamura is a scholar working on Dermatology, Urology and Oncology, having authored 184 papers that have together received 3.4k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (31 papers), Cancer Immunotherapy and Biomarkers (25 papers), Dermatology and Skin Diseases (22 papers), Urinary and Genital Oncology Studies (20 papers), Prostate Cancer Treatment and Research (19 papers), Drug-Induced Adverse Reactions (14 papers), Prostate Cancer Diagnosis and Treatment (12 papers) and Cutaneous lymphoproliferative disorders research (12 papers). The work is most often cited by research in Dermatology (872 citations), Urology (442 citations) and Immunology (1.0k citations). Motonobu Nakamura has collaborated with scholars based in Japan, Germany and United States. Frequent co-authors include Y. Tokura, Yu Sawada, Kenji Kabashima, Tasuku Honjo, Ryosuke Hino, Yu Kato, Taku Okazaki, Hiroaki Yagi, Natsuko Saito‐Sasaki and Ralf Paus. Their work appears in journals such as International Journal of Molecular Sciences, Anticancer Research, The Journal of Dermatology, European Journal of Dermatology and Acta Dermato Venereologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.